New strategies for improved tuberculosis vaccines (Old ID 23218)

Principal Investigator

Tuberculosis is a major global public health problem and continues to cause significant morbidity and mortality due to the low efficiency of the only licensed anti-tuberculosis vaccine, BCG. This project aims to produce novel, highly efficacious vaccination regimens against tuberculosis, especially pulmonary tuberculosis, which is currently the most difficult manifestation of infection to control. The results of this project have the potential to not only save millions of lives in the developing world but also to decrease socioeconomic burden of tuberculosis, particularly in the context of HIV co-infection.

01 Jan 2018 - 31 Dec 2021

N/A